Jane E. Lamerdin

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 6934: Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms

  Cancer Research · 2026-04-03

• Abstract 5543: Mechanism-driven cell-based assays to screen & characterize bi-specific antibodies

  Cancer Research · 2026-04-03

• Abstract 6744: Why the analytical development of agonistic antibodies is challenging? A comprehensive strategy to unlock their characterization for immunotherapy and autoimmunity

  Cancer Research · 2025-04-21

• Abstract 6020: Quantitative measurement of Fc-mediated ADCC & ADCP activity of therapeutic antibodies using a robust, universal cell-based assay platform

  Cancer Research · 2025-04-21

• Suite of Biochemical and Cell-Based Assays for the Characterization of Kirsten Rat Sarcoma (KRAS) Inhibitors and Degraders

  ACS Pharmacology & Translational Science · 2024-12-02 · 4 citations

• A Suite of Biochemical and Cell-Based Assays for the Characterization of KRAS Inhibitors and DegradersPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2024-07-23